Stealth Pathogens and Fertility: What “Silent Infection” Really Means

Some infections are easy to notice. They cause fever, pain, a rash or an obvious acute illness. Others have a short acute window and can then persist, become latent or reactivate without producing the symptoms most people associate with an infection.

In complex fertility cases, this creates a difficult question: could an infection still matter when you do not feel acutely unwell and your standard results appear normal?

My answer is that it is best to test and be aware of what you are dealing with as early as possible. “Stealth pathogens” are real, difficult to deal with and can lead to an unsuccessful IVF cycle or pregnancy loss due to infection and, potentially, blood clotting in the placenta. “Stealth pathogens” is a clinical umbrella term for organisms capable of persistence, latency, intracellular survival or immune evasion.

This is what complex cases keep asking of me: “What part of this fertility story has not yet been adequately explained? What can realistically be explored using the most advanced testing options available, and what will make the most difference when treated?”

What is a stealth pathogen?

The term is used to describe an organism that is difficult to identify or clear because it can do one or more of the following:

• Persist at a low level after the initial infection.
• Become latent, remaining in the body without continuous active replication.
• Live inside cells, where ordinary antibody or sample-based testing may provide only part of the picture.
• Form cysts, so that the organism is not present in the sample collected on the day of testing.
• Reactivate when immune conditions change.
• Produce few or non-specific symptoms, such as fatigue, recurrent rashes or neurological sensations that are not immediately connected with fertility.

Herpesviruses are the clearest familiar example of latency: after the original infection, the virus remains in the body and may reactivate later. Chlamydia trachomatis is an intracellular bacterium with a different biology. Toxoplasma gondii can form persistent tissue cysts.

Does a silent infection necessarily cause infertility?

No, but an ongoing chronic infection can lead to immune-system reactivation in a woman and to defects in sperm morphology; both might lead to a lack of embryo progression or challenges post-implantation.

It is understandable that this work is emerging alongside Reproductive Immunology and will take time to be reflected in mainstream medicine.

Where might infection intersect with fertility?

Conception is not one event. It is a sequence:

1. egg and sperm develop;
2. fertilisation occurs;
3. the embryo develops;
4. implantation takes place;
5. the placenta forms and pregnancy progresses.

Infection or inflammation could, in principle, influence different points in that sequence through different mechanisms. These may include local inflammation in the reproductive tract, oxidative stress affecting sperm, altered endometrial receptivity, direct tissue effects, or maternal infection during pregnancy.

The evidence is not equally strong for every pathogen or every proposed mechanism. The effects of toxoplasmosis, varicella-zoster virus, herpes or CMV infection during pregnancy are established clinical concerns. By contrast, the contribution of latent or reactivated infection to failed implantation or recurrent early loss is much less explored, mainly due to bias and a lack of adequate testing.

Why fertility may be the first visible problem

Many fertility patients are younger than the typical person presenting with a complex chronic illness. They may still be working, exercising and managing daily life. The body can compensate for a great deal before a broad collection of symptoms becomes obvious.

For some people, the reproductive system is where that loss of resilience first becomes visible:

• ovarian stimulation produces an unexpectedly poor response;
• embryos repeatedly stop developing;
• a good-quality embryo does not implant;
• pregnancies begin but end early;
• semen parameters remain poor despite apparently appropriate preparation.

None of these patterns is specific to an infection; each has several possible causes, including embryo genetics, age-related factors, anatomy, endocrine health, autoimmune disease, sperm DNA damage and chance. But when the standard explanation does not account for the whole history, a carefully chosen infectious or immune question may become reasonable.

What standard fertility testing usually does well

Standard fertility care is not “missing everything”. It is designed to identify common, actionable causes efficiently. It assesses areas such as ovulation, ovarian reserve, tubal patency, uterine anatomy and basic semen parameters. It is officially recommended that “appropriately sensitive Chlamydia screening before uterine instrumentation” be carried out.

But the testing methodology is dated and uses urine or antibody testing, whereas chronic Chlamydia is an intracellular, cyst-forming pathogen that primarily resides in the peritoneum—thus affecting tubal patency—and does not create an antibody response. Both issues require adequate testing, e.g. via a T-lymphocyte reaction (EliSpot or iSpot).

Current professional guidance does not recommend routine broad infection or immune screening for everyone with recurrent miscarriage, primarily because of a lack of funding, as explicitly stated on the website of at least one established reproductive agency.

When might a deeper infectious history be worth discussing?

The threshold should be clinical context. Questions may become more relevant when the history includes:

• known previous sexually transmitted infection or pelvic inflammatory disease;
• tubal damage or unexplained pelvic inflammation;
• recurrent or unusual rashes, shingles-like nerve pain, or herpesvirus symptoms such as cold sores;
• a significant travel, animal, food, occupational or tick exposure history;
• persistent abnormalities in semen, sperm DNA fragmentation or inflammatory markers;
• recurrent microbiome disruption that does not respond as expected;
• immune suppression or a condition that changes infection risk;
• a pattern of failed implantation or loss that remains unexplained after recommended evaluation.

The absence of these clues does not prove that infection is irrelevant. Their presence does not prove causation. They help determine which pathogens are most likely culprits.

Why one negative result may not answer every question

Different tests look for different biological signals.

• PCR or another nucleic-acid test looks for genetic material from an organism in a particular sample.
• IgG and IgM serology measures parts of the antibody response.
• Avidity testing can sometimes help estimate whether an antibody response is more recent or more established.
• Cellular immune assays, offered by specialist laboratories including ArminLabs, measure aspects of T-cell response for selected organisms.

These methods are not interchangeable. A negative swab or PCR might be insufficient to fully rule out the infection. The result has to be read alongside the history and other tests, with an understanding of the methodology—i.e. which precise question the test was intended to answer.

Both partners should participate in a complex fertility investigation

Fertility investigation is still frequently asymmetric. The female partner may undergo repeated blood tests, scans and procedures while the male investigation stops after count, motility and morphology.

That is not enough for a genuinely shared reproductive picture. Infection and inflammation may affect sperm quality, oxidative stress and DNA integrity; semen can also carry organisms that matter to the reproductive tract.

Both partners should participate in a complex fertility investigation because half of the embryo’s DNA comes from the male partner, who also contributes genetic material to the placenta. Placental insufficiency—read: blood clotting—is one of the key contributors to second-trimester pregnancy loss, and a shared microbial and sexual ecosystem cannot be understood by repeatedly testing only one person.

A practical way to investigate

The most practical and effective approach is to start with a review, where we look at the full timeline and select tests according to the unanswered clinical questions. From there, the investigation is selective and staged:

1. Build a precise timeline of fertility events, symptoms, exposures, previous treatment and testing.
2. Identify the unanswered clinical questions.
3. Choose the widest set of tests capable of answering those questions from the start, to optimise time.
4. Interpret every result according to the organism and method used.
5. Diagnosis and any prescribed treatment should be provided by a medical professional.
6. Retest before making any major reproductive decisions.

This is a data-led investigation, not guesswork, but at the same time it is not a promise that one hidden pathogen explains everything.

Established evidence, emerging evidence and clinical observation

Throughout this series, I will use those three categories openly.

Established evidence includes recognised risks such as primary maternal infection with particular organisms during pregnancy, recommended STI screening in defined settings and preconception assessment of vaccination status.

Emerging evidence includes questions for which plausible mechanisms and early studies exist, but clinical guidance has not established routine testing or treatment.

Clinical observation describes patterns I repeatedly see in complex cases. Observation can generate a valuable question; it cannot, on its own, prove causation.

I do not think patients are better served by knowing exactly where the evidence is firm, where it is still developing and where a decision has to be individual.

The question to take forward

If your fertility history has been labelled “unexplained”, the next step is to ask whether your existing investigation adequately explains the stage at which things keep going wrong—and whether anything in the wider history justifies looking further.

Before booking, you may want to familiarise yourself with my methodology. If you would like me to review the investigations you already have and tell you whether this work is relevant to your case, you can book an Introductory Fertility Review. If repeated good-quality embryo transfers are part of your history, you may also begin with the free IVF Blind Spots guide.

This article is educational and does not replace individual medical advice, diagnosis or treatment.